Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Kodak Launches New Imaging Agent Product Line for Research Applications

Abstract:
Enables Early Disease Detection and Treatment

Kodak Launches New Imaging Agent Product Line for Research Applications

New Haven, CT | Posted on February 28th, 2007

Eastman Kodak Company's Molecular Imaging Systems group announced the introduction of KODAK X-SIGHT Imaging Agents, a novel line of imaging agents for in vivo molecular imaging applications. The new product line will be shown at the 14th International Molecular Medicine Tri-Conference, beginning today in San Francisco, Calif., and running through March 2.

In vivo molecular imaging allows non-invasive measurement of biological processes within a living organism. In contrast to conventional diagnostic imaging that highlights conditions caused by disease, molecular imaging identifies molecular abnormalities that are the origin of disease at a very early stage, which can expedite the development of treatment options that could help cure that disease.

Once attached to a molecule and injected into an organism, the KODAK X-Sight imaging agents will travel to the target (such as a tumor) and highlight the region of interest. X-Sight imaging agents are non-toxic, making them safe for research studies in areas such as oncology, cardiology, diabetes, and inflammation, to name a few. They are uniquely designed to offer significant advantages over currently available agents, enabling researchers to perform pioneering research studies that could lead to a better understanding of the origin of these diseases.

This new product line leverages Kodak's 50 years of dye chemistry and nanotechnology expertise, to produce state-of-the-art nanoparticle products. X-Sight imaging agents deliver superior brightness and enhanced stability, providing researchers a versatile platform for molecular imaging. KODAK X-Sight imaging agents are available in several distinct varieties and can be adapted to a wide range of applications.

"The launch of X-Sight Imaging Agents, is a significant milestone toward offering our customers a complete solution of systems and agents to advance their research," commented Shahram Hejazi, PhD, Worldwide General Manager of Kodak's Molecular Imaging Systems division. "This introduction strengthens our leadership in the molecular imaging arena as we move forward to bridge the gap between preclinical and clinical applications."

Together with Kodak's In-Vivo Imaging Systems, the X-Sight Imaging Agent product line further expands the breadth of leading edge solutions offered from Kodak to the medical research community to accelerate life science and drug discovery research. X-Sight imaging agents are currently available for preclinical use in the United States and will be launched worldwide in March. Kodak plans to introduce additional imaging agents throughout the year.

####

About Kodak’s Molecular Imaging Systems Group
Eastman Kodak Company’s Molecular Imaging Systems group--part of Kodak’s Health Group--develops and markets high performance digital imaging systems, imaging agents, film and accessories for the life science research and drug discovery/development market segments.

For more information, visit http://www.kodak.com/go/molecular or call 1-877-747-4357, express code 7. Outside of the United States, call 203-786-5657.

Kodak and X-Sight are trademarks of Eastman Kodak Company.

For more information, please click here

Contacts:
Eastman Kodak Company
Alice Huang, 408-464-1151

Copyright © Business Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

NYU Researchers Break Nano Barrier to Engineer the First Protein Microfiber October 23rd, 2014

Iranian Scientists Apply Nanotechnology to Produce Surgery Suture October 23rd, 2014

RF Heating of Magnetic Nanoparticles Improves the Thawing of Cryopreserved Biomaterials October 23rd, 2014

Sopping up proteins with thermosponges: Researchers develop novel nanoparticle platform that proves effective in delivering protein-based drugs October 22nd, 2014

Announcements

Iran to Hold 3rd Int'l Engineering Materials, Metallurgy Conference October 25th, 2014

Haydale Secures Exclusive Development and Supply Agreement with Tantec A/S: New reactors to be built and commissioned by Tantec A/S represent another step forward towards the commercialisation of graphene October 24th, 2014

QuantumWise guides the semiconductor industry towards the atomic scale October 24th, 2014

Strengthening thin-film bonds with ultrafast data collection October 23rd, 2014

Tools

Haydale Secures Exclusive Development and Supply Agreement with Tantec A/S: New reactors to be built and commissioned by Tantec A/S represent another step forward towards the commercialisation of graphene October 24th, 2014

National Synchrotron Light Source II Achieves 'First Light' October 23rd, 2014

Advancing thin film research with nanostructured AZO: Innovnano’s unique and cost-effective AZO sputtering targets for the production of transparent conducting oxides October 23rd, 2014

NIST offers electronics industry 2 ways to snoop on self-organizing molecules October 22nd, 2014

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE